Connection
Peter Crooks to Quinoxalines
This is a "connection" page, showing publications Peter Crooks has written about Quinoxalines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.543 |
|
|
|
-
Sonar VN, Venkatraj M, Parkin S, Crooks PA. rac-(Z)-2-(2-Thienylmethylene)-1-azabicyclo[2.2.2]octan-3-ol. Acta Crystallogr C. 2007 Aug; 63(Pt 8):o493-5.
Score: 0.306
-
Crooks PA, Bardo MT, Dwoskin LP. Nicotinic receptor antagonists as treatments for nicotine abuse. Adv Pharmacol. 2014; 69:513-51.
Score: 0.120
-
Dwoskin LP, Pivavarchyk M, Joyce BM, Neugebauer NM, Zheng G, Zhang Z, Bardo MT, Crooks PA. Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. Nebr Symp Motiv. 2009; 55:31-63.
Score: 0.085
-
Holt JC, Kewin K, Jordan PM, Cameron P, Klapczynski M, McIntosh JM, Crooks PA, Dwoskin LP, Lysakowski A. Pharmacologically distinct nicotinic acetylcholine receptors drive efferent-mediated excitation in calyx-bearing vestibular afferents. J Neurosci. 2015 Feb 25; 35(8):3625-43.
Score: 0.032